date,title,source
Oct-18-18,Watertown biotech Selecta halts cancer drug trial after patient dies,American City Business Journals
Oct-23-18,"Selecta Biosciences Presents New Interim Data from Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at ACR 2018",GlobeNewswire
Oct-24-18,Selecta shares cut nearly in half since gout drug data,American City Business Journals
Nov-01-18,"Selecta Biosciences to Report Third Quarter 2018 Financial Results and Update on SEL-212 Development Strategy, including Planned Head-to-Head Study versus Krystexxa",GlobeNewswire
Nov-06-18,Selecta Biosciences to Present at the Stifel Healthcare Conference 2018,GlobeNewswire
